Joshua R. Disbrow
2017 - AYTU BIOPHARMA
In 2017, Joshua R. Disbrow earned a total compensation of $1.1M as Chief Executive Officer at AYTU BIOPHARMA.
Compensation breakdown
| Option Awards | $189,000 |
|---|---|
| Salary | $250,000 |
| Stock Awards | $614,000 |
| Total | $1,053,000 |
Disbrow received $614K in stock awards, accounting for 58% of the total pay in 2017.
Disbrow also received $189K in option awards and $250K in salary.
Rankings
In 2017, Joshua R. Disbrow's compensation ranked 8,749th out of 14,666 executives tracked by ExecPay. In other words, Disbrow earned more than 40.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,749 out of 14,666 | 40th |
Division Manufacturing | 3,331 out of 5,768 | 42nd |
Major group Chemicals And Allied Products | 1,127 out of 2,074 | 46th |
Industry group Drugs | 896 out of 1,730 | 48th |
Industry Pharmaceutical Preparations | 703 out of 1,329 | 47th |
Source: SEC filing on February 25, 2019.
Disbrow's colleagues
We found two more compensation records of executives who worked with Joshua R. Disbrow at AYTU BIOPHARMA in 2017.
News
AYTU BIOPHARMA CEO Joshua Disbrow's 2023 pay rises 20% to $708K
May 10, 2024
AYTU BIOPHARMA CEO Joshua Disbrow's 2021 pay jumps 291% to $6.2M
April 7, 2022
AYTU BIOPHARMA CEO Joshua Disbrow's 2020 pay jumps 52% to $1.6M
April 16, 2021
AYTU BIOPHARMA CEO Joshua Disbrow's 2019 pay jumps 72% to $1M
March 5, 2020
AYTU BIOPHARMA CEO Joshua Disbrow's 2018 pay falls 42% to $606K
February 25, 2019